Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma.
Saved in:
| Title: | Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma. |
|---|---|
| Authors: | Yang Y; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA., Ronsley R; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy, Department of Pediatrics, Seattle Children's Hospital and the University of Washington.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Kilburn L; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC 20816, USA., Kim A; Department of Medical Engineering, University of South Florida, Tampa, FL 33620, USA., Wechsler-Reya RJ; Department of Neurology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA., Yang ZJ; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA. |
| Source: | Molecular therapy. Oncology [Mol Ther Oncol] 2026 May 14; Vol. 34 (2), pp. 201235. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918752083706676 Publication Model: eCollection Cited Medium: Print ISSN: 2950-3299 (Print) Linking ISSN: 29503299 NLM ISO Abbreviation: Mol Ther Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42256204 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Yang+Y%22">Yang Y</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.<br /><searchLink fieldCode="AU" term="%22Ronsley+R%22">Ronsley R</searchLink>; The Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.; Division of Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cellular Therapy, Department of Pediatrics, Seattle Children's Hospital and the University of Washington.; Fred Hutchinson Cancer Center, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Kilburn+L%22">Kilburn L</searchLink>; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC 20816, USA.<br /><searchLink fieldCode="AU" term="%22Kim+A%22">Kim A</searchLink>; Department of Medical Engineering, University of South Florida, Tampa, FL 33620, USA.<br /><searchLink fieldCode="AU" term="%22Wechsler-Reya+RJ%22">Wechsler-Reya RJ</searchLink>; Department of Neurology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.<br /><searchLink fieldCode="AU" term="%22Yang+ZJ%22">Yang ZJ</searchLink>; Nuclear Dynamics and Cancer Program, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA.; Cancer Epigenetics Institute, Fox Chase Cancer Center, Temple Health System, Philadelphia, PA 19111, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918752083706676%22">Molecular therapy. Oncology</searchLink> [Mol Ther Oncol] 2026 May 14; Vol. 34 (2), pp. 201235. <i>Date of Electronic Publication: </i>2026 May 14 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918752083706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2950-3299 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229503299%22">29503299 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42256204 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omton.2026.201235 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 201235 Titles: – TitleFull: Differentiation-inducing triiodothyronine enhances chemotherapy and suppresses post-treatment tumor regrowth in medulloblastoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang Y – PersonEntity: Name: NameFull: Ronsley R – PersonEntity: Name: NameFull: Kilburn L – PersonEntity: Name: NameFull: Kim A – PersonEntity: Name: NameFull: Wechsler-Reya RJ – PersonEntity: Name: NameFull: Yang ZJ IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 05 Text: 2026 May 14 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 2950-3299 Numbering: – Type: volume Value: 34 – Type: issue Value: 2 Titles: – TitleFull: Molecular therapy. Oncology Type: main |
| ResultId | 1 |
